These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 29128092)

  • 1. Quality requirements for allergen extracts and allergoids for allergen immunotherapy.
    Zimmer J; Bonertz A; Vieths S
    Allergol Immunopathol (Madr); 2017 Dec; 45 Suppl 1():4-11. PubMed ID: 29128092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allergoids for Allergy Treatment.
    Carnes J; Gallego MT; Moya R; Iraola V
    Recent Pat Inflamm Allergy Drug Discov; 2018; 12(2):110-119. PubMed ID: 29473530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of allergoid immunotherapy: is cat allergy a suitable target?
    Nguyen NT; Raskopf E; Shah-Hosseini K; Zadoyan G; Mösges R
    Immunotherapy; 2016; 8(3):331-49. PubMed ID: 26860435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
    Rossi RE; Monasterolo G
    Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proposals for harmonization of allergens regulation in the European Union.
    Timón M
    Allergol Immunopathol (Madr); 2017 Dec; 45 Suppl 1():1-3. PubMed ID: 29108764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergen extracts for immunotherapy: to mix or not to mix?
    Nony E; Martelet A; Jain K; Moingeon P
    Expert Rev Clin Pharmacol; 2016; 9(3):401-8. PubMed ID: 26652799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European allergen extract units and potency: review of available information.
    Larenas-Linnemann D; Cox LS;
    Ann Allergy Asthma Immunol; 2008 Feb; 100(2):137-45. PubMed ID: 18320915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory Requirements for the Quality of Allergen Products for Allergen Immunotherapy of Food Allergy.
    Englert L; Mahler V; Bonertz A
    Curr Allergy Asthma Rep; 2021 May; 21(5):32. PubMed ID: 33970347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depigmented and polymerised house dust mite allergoid: allergen content, induction of IgG4 and clinical response.
    Gallego MT; Iraola V; Himly M; Robinson DS; Badiola C; García-Robaina JC; Briza P; Carnés J
    Int Arch Allergy Immunol; 2010; 153(1):61-9. PubMed ID: 20357486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of allergenic extracts from different origins: the value of the FDA's bioequivalent allergy unit (BAU).
    Passalacqua G; Sastre J; Pfaar O; Wahn U; Demoly P
    Expert Rev Clin Immunol; 2016 Jul; 12(7):733-9. PubMed ID: 27215895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of allergenicity and immunogenicity of an intact allergen vaccine and commercially available allergoid products for birch pollen immunotherapy.
    Lund L; Henmar H; Würtzen PA; Lund G; Hjortskov N; Larsen JN
    Clin Exp Allergy; 2007 Apr; 37(4):564-71. PubMed ID: 17430354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing the quality of Myrmecia pilosula (Jack Jumper) ant venom for use in in vitro and in vivo diagnoses of allergen sensitization and in allergen immunotherapy.
    Wanandy T; Dwyer HE; McLean L; Davies NW; Nichols D; Gueven N; Brown SGA; Wiese MD
    Clin Exp Allergy; 2017 Nov; 47(11):1478-1490. PubMed ID: 28756642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allergen immunotherapy.
    Mannan S
    Immunotherapy; 2017 Nov; 9(15):1199-1200. PubMed ID: 29130796
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular diagnosis and immunotherapy.
    Sastre J; Sastre-Ibañez M
    Curr Opin Allergy Clin Immunol; 2016 Dec; 16(6):565-570. PubMed ID: 27685663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of allergoids in allergen immunotherapy: from injective to sublingual route.
    Compalati E; Incorvaia C; Cavaliere C; Masieri S; Gargiulo A; Mistrello G; Frati F
    Eur Ann Allergy Clin Immunol; 2020 Sep; 52(5):195-204. PubMed ID: 32338477
    [No Abstract]   [Full Text] [Related]  

  • 16. The Impact on Allergy-Related Cells of a Birch Pollen Allergoid, with and without Monophosphoryl Lipid A, in Comparison with the Native Equivalent.
    Worm M; Ernst D; Kraller M; Babina M
    Int Arch Allergy Immunol; 2017; 172(1):20-26. PubMed ID: 28219062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of allergen vaccine potency.
    Esch RE
    Curr Allergy Asthma Rep; 2006 Sep; 6(5):402-6. PubMed ID: 16899202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standardization and Regulation of Allergen Products in the European Union.
    Zimmer J; Vieths S; Kaul S
    Curr Allergy Asthma Rep; 2016 Mar; 16(3):21. PubMed ID: 26874849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosing of European sublingual immunotherapy maintenance solutions relative to monthly recommended dosing of subcutaneous immunotherapy.
    Larenas-Linnemann DE; Mösges R
    Allergy Asthma Proc; 2016; 37(1):50-6. PubMed ID: 26831847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro evidence of efficacy and safety of a polymerized cat dander extract for allergen immunotherapy.
    Morales M; Gallego M; Iraola V; Taulés M; de Oliveira E; Moya R; Carnés J
    BMC Immunol; 2017 Feb; 18(1):10. PubMed ID: 28235411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.